M. Gherardi

发表

IL-12 and IL-18 act in synergy to clear vaccinia virus infection: involvement of innate and adaptive components of the immune system.

J. Ramírez, M. Esteban, M. Gherardi, 2003, The Journal of general virology.

Mucosal and systemic immune responses induced after oral delivery of vaccinia virus recombinants.

M. Esteban, M. Gherardi, 1999, Vaccine.

Attenuated poxviruses expressing a synthetic HIV protein stimulate HLA-A2-restricted cytotoxic T-cell responses.

J. Sirard, G. Pantaleo, M. Graf, 2004, Vaccine.

The combination of DNA vectors expressing IL-12 + IL-18 elicits high protective immune response against cutaneous leishmaniasis after priming with DNA-p36/LACK and the cytokines, followed by a booster with a vaccinia virus recombinant expressing p36/LACK.

M. Esteban, R. Gonzalo, E. Tapia, 2003, Microbes and infection.

Prime-Boost Immunization Schedules Based on Influenza Virus and Vaccinia Virus Vectors Potentiate Cellular Immune Responses against Human Immunodeficiency Virus Env Protein Systemically and in the Genitorectal Draining Lymph Nodes

A. García-Sastre, Susana Guerra, M. Esteban, 2003, Journal of Virology.

MVA-LACK as a safe and efficient vector for vaccination against leishmaniasis.

M. Esteban, G. Kochan, M. Gherardi, 2006, Microbes and infection.

Vaccine Efficacy against Malaria by the Combination of Porcine Parvovirus-Like Particles and Vaccinia Virus Vectors Expressing CS of Plasmodium

G. González-Aseguinolaza, M. Esteban, J. Rodríguez, 2012, PloS one.

IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner.

J. Ramírez, M. Esteban, D. Rodríguez, 1999, Journal of immunology.

HIV-1 Env in a Dose-Dependent Manner the Cellular Immune Response Against Virus Attenuates the Vector and Enhances IL-12 Delivery from Recombinant Vaccinia Zavala and

J. Ramírez, M. Esteban, J. Rodríguez, 1999 .

Induction of HIV Immunity in the Genital Tract After Intranasal Delivery of a MVA Vector: Enhanced Immunogenicity After DNA Prime-Modified Vaccinia Virus Ankara Boost Immunization Schedule 1

M. Esteban, M. Gherardi, E. Pérez-Jiménez, 2004, The Journal of Immunology.

Towards a new generation of vaccines: the cytokine IL-12 as an adjuvant to enhance cellular immune responses to pathogens during prime-booster vaccination regimens.

J. Ramírez, M. Esteban, M. Gherardi, 2001, Histology and histopathology.

Biology of Attenuated Modified Vaccinia Virus Ankara Recombinant Vector in Mice: Virus Fate and Activation of B- and T-Cell Immune Responses in Comparison with the Western Reserve Strain and Advantages as a Vaccine

J. Ramírez, M. Esteban, M. Gherardi, 2000, Journal of Virology.

Interleukin-12 (IL-12) Enhancement of the Cellular Immune Response against Human Immunodeficiency Virus Type 1 Env Antigen in a DNA Prime/Vaccinia Virus Boost Vaccine Regimen Is Time and Dose Dependent: Suppressive Effects of IL-12 Boost Are Mediated by Nitric Oxide

J. Ramírez, M. Esteban, M. Gherardi, 2000, Journal of Virology.

Boost Immunization Schedule DNA Prime-Modified Vaccinia Virus Ankara Vector: Enhanced Immunogenicity After Tract After Intranasal Delivery of a MVA Induction of HIV Immunity in the Genital

M. Esteban, J. Luis, M. Gherardi, 2004 .

Attenuated Modified Vaccinia Virus Ankara Can Be Used as an Immunizing Agent under Conditions of Preexisting Immunity to the Vector

J. Ramírez, M. Esteban, D. Rodríguez, 2000, Journal of Virology.

T-Cell Immune Responses Against Env from CRF12_BF and Subtype B HIV-1 Show High Clade-Specificity that Can Be Overridden by Multiclade Immunizations

M. Esteban, A. M. Rodríguez, J. Falivene, 2011, PloS one.

Recombinant poxviruses as mucosal vaccine vectors.

M. Esteban, M. Gherardi, M. Gherardi, 2005, The Journal of general virology.

Evaluation of different temperature-sensitive mutant phenotypes ofSalmonella enteritidis as vaccine potentials

M. Cerquetti, D. Sordelli, M. Gherardi, 1990, Current Microbiology.

Protective capacity of a temperature-sensitive mutant of Salmonella enteritidis after oral and intragastric inoculation in a murine model.

M. Cerquetti, V. García, D. Sordelli, 1993, Vaccine.